Physician profile
Ivan Mac
NPI 1689654592
$103,969.38
in general payments reported to CMS, 2019-2025
39 companies · $9,503 in 2025
The $9,503 reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $22K · 2021: $19K · 2022: $8,685 · 2023: $8,955 · 2024: $6,604 · 2025: $9,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Consulting Fee: $10K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,400 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,548.81 |
| Consulting Fee | $10,087.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,400.00 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $47,744.83 | 2019-2025 | Clareon, Hydrus Microstent, Lensx |
| Kala Pharmaceuticals, INC. | $10,879.21 | 2019-2022 | |
| Tearlab Corp | $10,566.39 | 2020-2024 | Scoutpro Osmolarity System, Tearlab Osmolarity System |
| Johnson & Johnson Surgical Vision, INC. | $9,227.85 | 2019-2025 | Intralase Fs Femtosec Laser, Compact Intuitiv, Ifs Advanced Femtosec Laser |
| Eyevance Pharmaceuticals LLC | $9,196.06 | 2019-2022 | |
| New World Medical,INC. | $1,340.03 | 2020-2025 | Streamline, Kahook Dual Blade, Clearpath |
| Abbvie INC. | $1,330.30 | 2022-2025 | |
| Harrow Eye, LLC | $1,148.02 | 2023-2025 | Vevye, Iheezo |
| Carl Zeiss Meditec Cataract Technology INC. | $1,085.89 | 2019-2023 | |
| Carl Zeiss Meditec USA, INC. | $1,050.35 | 2021-2025 | Visumax, Artevo 800, Veracity Surgical |
| Novartis Pharmaceuticals Corporation | $1,038.58 | 2020-2023 | |
| Bausch & Lomb Americas INC. | $1,008.17 | 2022-2025 | Miebo, Envista Mx60 Iol, Xiidra |
| Rxsight INC | $963.79 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $875.31 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $797.26 | 2024-2025 | Xdemvy |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $705.47 | 2019-2025 | Cequa, Xelpros |
| Alcon Research LLC | $603.67 | 2019-2025 | |
| Carl Zeiss Meditec, INC. | $589.04 | 2019-2023 | |
| Oyster Point Pharma, INC. | $578.79 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Glaukos Corporation | $502.22 | 2019-2025 | Idosetr, Istent Infinite |
| Lensar, INC. | $493.25 | 2024-2025 | Lensar Laser System |
| Biotissue Holdings INC. | $435.87 | 2021-2025 | |
| Ivantis, INC | $393.25 | 2019-2021 | |
| Allergan, INC. | $255.04 | 2019-2022 | |
| Staar Surgical Company | $210.75 | 2019 | |
| Astellas Pharma US INC | $185.07 | 2023-2024 | Izervay |
| Dompe US, INC. | $170.05 | 2021-2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $130.61 | 2019-2021 | |
| Bausch Health US, LLC | $102.44 | 2020 | |
| Amgen INC. | $77.35 | 2024-2025 | Tepezza |
| Quidel Corporation | $77.34 | 2019 | |
| Horizon Therapeutics Plc | $47.38 | 2022-2023 | Tepezza |
| Alimera Sciences, INC. | $38.22 | 2023-2024 | Iluvien, Yutiq |
| Johnson & Johnson Vision Care, INC. | $28.81 | 2024 | |
| Ani Pharmaceuticals, INC. | $20.67 | 2025 | Yutiq |
| Omeros Corporation | $19.50 | 2021 | |
| Sight Sciences, INC. | $19.08 | 2022 | |
| Ocular Therapeutix, INC. | $18.60 | 2019 | |
| Apellis Pharmaceuticals, INC. | $14.87 | 2023 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Mac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.